These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 18997759)

  • 1. What's fueling the biotech engine-2007.
    Aggarwal S
    Nat Biotechnol; 2008 Nov; 26(11):1227-33. PubMed ID: 18997759
    [No Abstract]   [Full Text] [Related]  

  • 2. What's fueling the biotech engine?
    Aggarwal S
    Nat Biotechnol; 2007 Oct; 25(10):1097-104. PubMed ID: 17921989
    [No Abstract]   [Full Text] [Related]  

  • 3. What's fueling the biotech engine--2010 to 2011.
    Aggarwal S
    Nat Biotechnol; 2011 Dec; 29(12):1083-9. PubMed ID: 22158359
    [No Abstract]   [Full Text] [Related]  

  • 4. Biotech drug market steadily expands.
    Lawrence S
    Nat Biotechnol; 2005 Dec; 23(12):1466. PubMed ID: 16333279
    [No Abstract]   [Full Text] [Related]  

  • 5. Bugs or drugs, tortoises or hares?
    Jacobs T
    Nat Biotechnol; 2005 Mar; 23(3):293. PubMed ID: 15765079
    [No Abstract]   [Full Text] [Related]  

  • 6. The 802 million dollars fallacy.
    Hodgson J
    Nat Biotechnol; 2004 Sep; 22(9):1076. PubMed ID: 15340464
    [No Abstract]   [Full Text] [Related]  

  • 7. Billion dollar babies--biotech drugs as blockbusters.
    Lawrence S
    Nat Biotechnol; 2007 Apr; 25(4):380-2. PubMed ID: 17420735
    [No Abstract]   [Full Text] [Related]  

  • 8. Deconstructing Myogen's market cap.
    Ransom J
    Nat Biotechnol; 2006 Mar; 24(3):227-8. PubMed ID: 16525363
    [No Abstract]   [Full Text] [Related]  

  • 9. Deal watch: Trends in platform technology deal-making.
    Walker J; Jacob J
    Nat Rev Drug Discov; 2009 Dec; 8(12):923. PubMed ID: 19949395
    [No Abstract]   [Full Text] [Related]  

  • 10. Biotechnology partnerships--medicine for an ailing industry?
    DeLamarter J
    Nat Biotechnol; 2003 Aug; 21(8):847-8. PubMed ID: 12894192
    [No Abstract]   [Full Text] [Related]  

  • 11. What's fueling the biotech engine-2009-2010.
    Aggarwal S
    Nat Biotechnol; 2010 Nov; 28(11):1165-71. PubMed ID: 21057482
    [No Abstract]   [Full Text] [Related]  

  • 12. Public biotech 2009-the numbers.
    Huggett B; Hodgson J; Lähteenmäki R
    Nat Biotechnol; 2010 Aug; 28(8):793-9. PubMed ID: 20697401
    [No Abstract]   [Full Text] [Related]  

  • 13. Aligning pharmaceutical innovation with medical need.
    Nathan C
    Nat Med; 2007 Mar; 13(3):304-8. PubMed ID: 17342145
    [No Abstract]   [Full Text] [Related]  

  • 14. Growing pains for biopharmaceuticals.
    Ashton G
    Nat Biotechnol; 2001 Apr; 19(4):307-11. PubMed ID: 11283578
    [No Abstract]   [Full Text] [Related]  

  • 15. Precompetitive research: a new prescription for drug development?
    Woodcock J
    Clin Pharmacol Ther; 2010 May; 87(5):521-3. PubMed ID: 20407454
    [No Abstract]   [Full Text] [Related]  

  • 16. Gaining medical momentum.
    Blake D
    Nature; 2004 Jun; 429(6991 Suppl):19-23. PubMed ID: 15175707
    [No Abstract]   [Full Text] [Related]  

  • 17. The further evolution of biotech.
    Nagle T; Berg C; Nassr R; Pang K
    Nat Rev Drug Discov; 2003 Jan; 2(1):75-9. PubMed ID: 12509762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What's fueling the biotech engine-2012 to 2013.
    Aggarwal RS
    Nat Biotechnol; 2014 Jan; 32(1):32-9. PubMed ID: 24406926
    [No Abstract]   [Full Text] [Related]  

  • 19. Patent reform in the US: what's at stake for pharmaceutical innovation?
    Yancey A; Stewart CN
    Expert Opin Ther Pat; 2010 May; 20(5):603-8. PubMed ID: 20402544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biotech patents-business as usual?
    Lawrence S
    Nat Biotechnol; 2008 Dec; 26(12):1326. PubMed ID: 19060861
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.